Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

APOE Alleles and Diet in Brain Aging and Alzheimer’s Disease
Hussein N. Yassine, Caleb E. Finch
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Ana‐Caroline Raulin, Sydney V. Doss, Zachary A. Trottier, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 320
Western diet as a trigger of Alzheimer’s disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration
Angelika Więckowska‐Gacek, Anna Mietelska‐Porowska, Małgorzata Wydrych, et al.
Ageing Research Reviews (2021) Vol. 70, pp. 101397-101397
Open Access | Times Cited: 237
APOE and Alzheimer’s Disease: From Lipid Transport to Physiopathology and Therapeutics
Mohammed Amir Husain, Benoît Laurent, Mélanie Plourde
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 216
Gene–environment interactions in Alzheimer disease: the emerging role of epigenetics
Lucia Migliore, Fabio Coppedè
Nature Reviews Neurology (2022) Vol. 18, Iss. 11, pp. 643-660
Closed Access | Times Cited: 122
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease
Oveis Jamialahmadi, Rosellina Margherita Mancina, Ester Ciociola, et al.
Gastroenterology (2021) Vol. 160, Iss. 5, pp. 1634-1646.e7
Open Access | Times Cited: 113
Non‐alcoholic fatty liver disease‐related risk of cardiovascular disease and other cardiac complications
Christopher D. Byrne, Giovanni Targher
Diabetes Obesity and Metabolism (2021) Vol. 24, Iss. S2, pp. 28-43
Open Access | Times Cited: 78
APOE2, E3, and E4 differentially modulate cellular homeostasis, cholesterol metabolism, and inflammatory response in isogenic iPSC-derived astrocytes
Sherida M. de Leeuw, Aron W.T. Kirschner, Karina Lindner, et al.
Stem Cell Reports (2021) Vol. 17, Iss. 1, pp. 110-126
Open Access | Times Cited: 70
Nutrition state of science and dementia prevention: recommendations of the Nutrition for Dementia Prevention Working Group
Hussein N. Yassine, Cécilia Samieri, Gill Livingston, et al.
The Lancet Healthy Longevity (2022) Vol. 3, Iss. 7, pp. e501-e512
Open Access | Times Cited: 65
APOE Genotype and Alzheimer’s Disease: The Influence of Lifestyle and Environmental Factors
Efthalia Angelopoulou, Yam Nath Paudel, Sokratis G. Papageorgiou, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 15, pp. 2749-2764
Closed Access | Times Cited: 61
Dynamic lipid turnover in photoreceptors and retinal pigment epithelium throughout life
Dominik Lewandowski, Christopher L. Sander, Aleksander Tworak, et al.
Progress in Retinal and Eye Research (2021) Vol. 89, pp. 101037-101037
Open Access | Times Cited: 60
Global and local ancestry modulate APOE association with Alzheimer’s neuropathology and cognitive outcomes in an admixed sample
Michel Satya Naslavsky, Cláudia Kimie Suemoto, Luciano Abreu Brito, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 11, pp. 4800-4808
Open Access | Times Cited: 56
Omega-3 fatty acids and cognitive function
Francine K. Welty
Current Opinion in Lipidology (2022) Vol. 34, Iss. 1, pp. 12-21
Closed Access | Times Cited: 46
Apolipoprotein E and sex modulate fatty acid metabolism in a prospective observational study of cognitive decline
Raúl González‐Domínguez, Pol Castellano‐Escuder, Sophie Lefèvre‐Arbogast, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 43
The Role of Astrocytes in Synapse Loss in Alzheimer's Disease: A Systematic Review
Lianne A. Hulshof, Danny van Nuijs, Elly M. Hol, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 39
Alzheimer’s Disease as Type 3 Diabetes: Understanding the Link and Implications
Mateusz Kciuk, Weronika Kruczkowska, Julia Gałęziewska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11955-11955
Open Access | Times Cited: 11
APOE4 is associated with elevated blood lipids and lower levels of innate immune biomarkers in a tropical Amerindian subsistence population
Angela R. García, Caleb E. Finch, Margaret Gatz, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 46
How Important Are Genes to Achieve Longevity?
Calogero Caruso, Mattia Emanuela Ligotti, Giulia Accardi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5635-5635
Open Access | Times Cited: 35
Uncoupling proteins as a therapeutic target for the development of new era drugs against neurodegenerative disorder
Rahul Kumar, T Amruthanjali, Siva Singothu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112656-112656
Open Access | Times Cited: 34
Ketogenic interventions in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease: A systematic review and critical appraisal
Jeffrey L. B. Bohnen, Roger L. Albin, Nicolaas I. Bohnen
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 18
Targeting epigenetics: A novel promise for Alzheimer’s disease treatment
Danko Jeremic, Lydia Jiménez‐Díaz, Juan D. Navarro‐López
Ageing Research Reviews (2023) Vol. 90, pp. 102003-102003
Closed Access | Times Cited: 18
Characterizing the pathogenicity of genetic variants: the consequences of context
Timothy H. Ciesielski, Giorgio Sirugo, Sudha K. Iyengar, et al.
npj Genomic Medicine (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Precision medicine and nucleotide-based therapeutics to treat MASH
Andrea Caddeo, Stefano Romeo
Clinical and Molecular Hepatology (2024)
Open Access | Times Cited: 7
Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study
Audrey Low, Maria A Prats‐Sedano, Elizabeth McKiernan, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 27
Nutritional metabolism and cerebral bioenergetics in Alzheimer's disease and related dementias
Hussein N. Yassine, Wade Self, Bilal E. Kerman, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 3, pp. 1041-1066
Open Access | Times Cited: 26
A multi‐hit hypothesis for an APOE4‐dependent pathophysiological state
Oliver Steele, Alexander Cameron Stuart, Lucy J. Minkley, et al.
European Journal of Neuroscience (2022) Vol. 56, Iss. 9, pp. 5476-5515
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top